Group B (=low risk of allogenic rejection, low risk for autoimmunity) included 11 T1D islet recipients with one or two HLA DR matches, but mismatched for HLA-DR3 and HLA-DR4 (independently of HLA-A and HLA-B matching). This evidence concerns the gene HLA-A and type 1 diabetes mellitus.